The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.
about
B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survivalCostimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetPredictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma.Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapyB7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.Tryptophan-degrading enzymes in tumoral immune resistance.Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cells.Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma.Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityThe association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.High CD4⁺ T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancerCharacterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens.The Impact of Tonsillectomy upon the Risk of Oropharyngeal Carcinoma Diagnosis and Prognosis in the Danish Cancer RegistryThe relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer.Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients.Suppression of T-cell responses by tumor metabolites.Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches.Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents.PD-1 blockade in renal cell carcinoma: to equilibrium and beyondAnti-PD-L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma.Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer.B7-H4 expression and its role in interleukin-2/interferon treatment of clear cell renal cell carcinoma.Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.Renal cell carcinoma: molecular characterization and evolving treatment paradigms.Apoptosis induction of K562 cells by lymphocytes: an AFM study.Effect of host immunity on metastatic potential in renal cell carcinoma: the assessment of optimal in vivo models to study metastatic behavior of renal cancer cells.Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.T regulatory cell markers in oral squamous cell carcinoma: Relationship with survival and tumor aggressiveness.
P2860
Q24550945-D5F1F87C-D52F-472D-A3B3-E4893CA2D471Q24559442-C93FFCA1-0BC9-4C2D-A88B-948D5D6A9580Q33684941-ADE9A553-7879-43D5-8E02-DE7E833B3D7BQ33730033-3CDEB0B7-05BC-4307-8961-F8EE1288D424Q34501651-C2456718-A756-48CB-BD04-896F950692E7Q34564433-E62DA18C-5057-4329-A1C1-7D68AC796ADCQ35042385-10ED6198-F351-41AF-802A-B80A7288E60FQ35065243-F378977B-F962-41DF-A27A-9F243A55CC0AQ35527136-A686D728-BDD7-4B94-A9BF-A43C06F5D9FDQ35588434-F44FBEC3-6EDF-4F7F-949A-FAE4D85D344CQ35625163-884847E0-2D3C-4E42-BABC-AEFEE1F3CF6BQ35682006-8B55A97D-6F8A-49F7-B442-A7C4A961C246Q36261897-3700D6D9-F9B3-4A66-A49F-2871B29615DCQ36413093-35FAA665-8869-496A-BA56-A360BC779736Q36486902-C42A88F9-1E7C-4E25-B83E-8499A1840F64Q36611805-0EF4B0D0-F2B4-42CA-A9BC-BE7E66BB1799Q36612383-C5D18755-65DC-4B74-B2B9-74C4C9DF628BQ36616245-ABC1696D-80F4-4C3E-A60D-3873990E60C9Q36935954-840EF7E3-58B8-4EC7-93C8-CB513A0BB5E9Q37074226-73E00DAB-24DC-4B1D-B0FF-B8C5CBAC253BQ37148917-608D14B6-F9A8-4ED9-889E-A43D4F4F1AB3Q37619675-D66C426B-D917-4EC6-8DCC-994221F417E9Q37650629-F9B8647C-FEF5-40FC-9628-B855BF650EA5Q37726404-BC5D9D3C-E6CD-4352-8D14-370970E7562EQ37829355-05B4DE02-C894-4D5D-A9BD-9223FDB02738Q38099023-1CAAF93F-A224-4284-84A4-73EE68C8D207Q38196855-E2590483-01D0-49BC-A676-3F3FC679C378Q38283974-66640B32-D06A-4CB0-B455-966CFEC5B735Q38742200-957D8E9B-B700-443D-8FD2-3B16A6268ECBQ38769921-E5776147-2DC9-454E-9327-9C9D691CCA59Q38800500-D81C707C-EFD6-4160-908F-56976CAB9F6EQ38933457-BB796FCE-44AA-4BDD-87BC-E1C7C70A3C00Q38964798-6DA1959D-57BC-4ADF-B464-A8DFA1D4F5ACQ39157961-0F7B4B5D-E450-40DF-87A2-8793FE8C7623Q39192872-0D7F4557-6267-4471-846A-9AF5FD82394FQ39417553-67031D0D-014A-436D-86C9-3CED92B34F1FQ39838078-4D37CB41-004B-49A7-BCCB-173E69DD26A5Q41431266-1094C52C-A9D9-4957-B576-C3FE8E2591A0Q41789122-3BB01E29-3B90-483F-B41A-E6F5D98B5EBCQ42323672-4846374C-8D58-425E-B24E-BF3638FEC0BC
P2860
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The relationship between T-lym ...... surgery for renal cell cancer.
@ast
The relationship between T-lym ...... surgery for renal cell cancer.
@en
type
label
The relationship between T-lym ...... surgery for renal cell cancer.
@ast
The relationship between T-lym ...... surgery for renal cell cancer.
@en
prefLabel
The relationship between T-lym ...... surgery for renal cell cancer.
@ast
The relationship between T-lym ...... surgery for renal cell cancer.
@en
P2093
P2860
P356
P1476
The relationship between T-lym ...... surgery for renal cell cancer
@en
P2093
A-M McNicol
E J Bromwich
M Aitchison
P A McArdle
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601400
P407
P577
2003-11-01T00:00:00Z